COLL Collegium Pharmaceutical Inc.

Collegium to Participate in Upcoming Investor Conferences

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences during the month of September:

H.C. Wainwright 23rd Annual Global Investment Conference

Format: Fireside chat

Date: Monday, September 13, 2021

Time: 7:00 – 7:30 AM Eastern Time

Cantor Virtual Global Healthcare Conference

Format: Virtual presentation

Date: Tuesday, September 28, 2021

Time: 8:00 – 8:30 AM Eastern Time

The presentations will be webcast live and may be accessed from the Investor section of the Company’s website: . A replay of the webcasts will be available on the Company’s website for approximately 30 days after the event.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at .

Contact:

MacDougall Advisors



EN
01/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Collegium Pharmaceutical Inc.

 PRESS RELEASE

Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Em...

Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community – Paris Hilton shares her personal ADHD journey and encourages others to see ADHD in a new light – –Together, Paris and Collegium are reframing common stereotypes and highlighting experiences that are often part of living with ADHD, including the importance of talking to a doctor and finding an individualized treatment plan –          Credit: Ashley Osborn STOUGHTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasd...

 PRESS RELEASE

Collegium to Participate in Upcoming Investor Conferences

Collegium to Participate in Upcoming Investor Conferences STOUGHTON, Mass., March 02, 2026 (GLOBE NEWSWIRE) --  (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Leerink Partners Global Healthcare ConferenceMonday, March 9, 2026Miami, FL Jefferies Biotech on the Beach SummitTuesday, March 10, 2026Miami, FL The Citizens Life Sciences ConferenceTuesday, March 10, 2026Miami, FL Barclays 28th Annual Global Healthcare ConferenceFireside Chat Date and Time: Wednesday, March 11, 2026 at 9:00 a.m. ETMiami, FL A live webcast of the fire...

 PRESS RELEASE

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results – Generated Quarterly Net Revenues of $205.4 Million, Up 13% Year-over-Year, and Record Full-Year Net Revenues of $780.6 Million, Up 24% Year-over-Year – – Generated Record Quarterly and Full-Year Jornay PM® Net Revenue of $45.9 Million and $148.9 Million, Up 57% and 48%, Respectively, Year-over-Year – – Generated Quarterly Pain Portfolio Net Revenues of $159.6 Million, Up 5% Year-over-Year, and Record Full-Year Pain Portfolio Net Revenues $631.7 Million, Up 6% Year-over-Year – – Ended 2025 with Cash, Cash Equivalents...

 PRESS RELEASE

Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pha...

Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- today announced a multi-year partnership with , an emerging biopharmaceutical leader in the Boston area, naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are working together to ensure that the club’s home games are welcoming and sensory-inclusive for all fans. As part of the partnership, the Collegium Sensory Room will be available at Gillette Stadium and Centreville Bank Stadium in 2026, and Wh...

 PRESS RELEASE

Collegium to Report Fourth Quarter and Full-Year 2025 Financial Result...

Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026 STOUGHTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) --  (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2025 financial results before the market opens on Thursday, February 26, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET. Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q4 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch